Published in Am J Public Health on May 01, 1998
Use of molecular subtyping to document long-term persistence of Corynebacterium diphtheriae in South Dakota. J Clin Microbiol (1999) 1.64
Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis (1999) 1.61
Persistence of a distinct Corynebacterium diphtheriae clonal group within two communities in the United States and Canada where diphtheria is endemic. J Clin Microbiol (2001) 1.07
Public health surveillance in the United States. Epidemiol Rev (1988) 8.58
A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 4.21
Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet (1996) 2.78
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
To end an epidemic. Lessons from the history of diphtheria. N Engl J Med (1992) 2.20
Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Public Health (1983) 1.77
Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994. J Clin Microbiol (1995) 1.76
Diphtheria among alcoholic urban adults. A decade of experience in Seattle. Ann Intern Med (1989) 1.67
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
Exudative pharyngitis possibly due to Corynebacterium pseudodiphtheriticum, a new challenge in the differential diagnosis of diphtheria. Emerg Infect Dis (1997) 1.43
Virulence, toxinogeny, and lysogeny in Corynebacterium diphtheriae. Ann N Y Acad Sci (1960) 1.43
Are we ready for diphtheria? A report from the Diphtheria Diagnostic Workshop, Atlanta, 11 and 12 July 1994. J Infect Dis (1995) 1.32
Diphtheria: prevalence of inapparent infection in a nonepidemic period. Am J Public Health Nations Health (1962) 1.32
Adult immunization. Summary of the National Vaccine Advisory Committee Report. JAMA (1994) 1.19
Monitoring progress toward US preschool immunization goals. JAMA (1992) 0.99
Suspected diphtheria in an Uzbek national: isolation of Corynebacterium pseudodiphtheriticum resulted in a false-positive presumptive diagnosis. Clin Infect Dis (1996) 0.89
Immunity to diphtheria and tetanus in inner-city women of childbearing age. Am J Public Health (1989) 0.88
Diphtheria immunity in Massachusetts--a study of three urban patient populations. Am J Med Sci (1984) 0.79
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73
Meningococcal disease. N Engl J Med (2001) 8.50
The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA (1990) 6.09
Intussusception among infants given an oral rotavirus vaccine. N Engl J Med (2001) 5.33
Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med (1986) 4.51
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA (2000) 4.36
Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1998) 4.19
Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 4.18
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med (1982) 3.69
Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis (1999) 3.48
Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA (1990) 3.41
Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA (1989) 3.39
Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis (1991) 3.29
Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27
The molecular epidemiology of cholera in Latin America. J Infect Dis (1993) 3.26
Use of polymerase chain reaction for detection of toxigenic Vibrio cholerae O1 strains from the Latin American cholera epidemic. J Clin Microbiol (1992) 3.10
Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med (1980) 3.01
Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol (1993) 3.01
Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis (1982) 2.96
Does influenza vaccination prevent asthma exacerbations in children? J Pediatr (2001) 2.89
Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci U S A (2001) 2.66
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med (1998) 2.46
Projections of AIDS morbidity and mortality in San Francisco. JAMA (1990) 2.42
Magnetic separation techniques in diagnostic microbiology. Clin Microbiol Rev (1994) 2.41
Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health (1985) 2.14
Molecular epidemiology of diphtheria in Russia, 1985-1994. J Infect Dis (1996) 2.12
Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA (1999) 2.09
Confounding in studies of adverse reactions to vaccines. Am J Epidemiol (1992) 2.06
Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis (2000) 2.05
The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J (1991) 1.99
Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA (1997) 1.99
Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis (2000) 1.97
Current approaches to the laboratory diagnosis of diphtheria. J Infect Dis (2000) 1.95
Measles herd immunity. The association of attack rates with immunization rates in preschool children. JAMA (1992) 1.85
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med (2001) 1.84
Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health (2001) 1.83
Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine (1989) 1.80
Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics (1996) 1.79
Hepatitis in day care centers: epidemiology and prevention. Rev Infect Dis (1986) 1.78
Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA (1989) 1.77
Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994. J Clin Microbiol (1995) 1.76
Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis (2000) 1.76
Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74
Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis (2000) 1.67
Risk factors for hepatitis A in day-care centers. J Infect Dis (1982) 1.66
The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol (1987) 1.66
Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64
Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol (1988) 1.63
Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis (1999) 1.61
Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC sentinel county hepatitis study I. Am J Med (1984) 1.61
Rubella seropositivity in the United States, 1988-1994. Clin Infect Dis (2001) 1.57
Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis (1998) 1.57
Probes and polymerase chain reaction for detection of food-borne bacterial pathogens. Int J Food Microbiol (1995) 1.54
Molecular subtyping of Salmonella enteritidis phage type 8 strains from the United States. J Clin Microbiol (1994) 1.54
Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53
Injection safety: a global challenge. Bull World Health Organ (1999) 1.52
Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis (1989) 1.51
Effect of immunoglobulin on hepatitis A in day-care centers. JAMA (1983) 1.51
The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health (1997) 1.50
Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. Biochemistry (1995) 1.48
Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies. Am J Epidemiol (1999) 1.48
Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dtxR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine. J Clin Microbiol (1996) 1.48
Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. J Clin Microbiol (2000) 1.48
Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clin Immunol Immunopathol (1986) 1.44
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol (1984) 1.43
Exudative pharyngitis possibly due to Corynebacterium pseudodiphtheriticum, a new challenge in the differential diagnosis of diphtheria. Emerg Infect Dis (1997) 1.43
Foodborne hepatitis A: evidence that microwaving reduces risk? J Infect Dis (1990) 1.43
Hepatitis B infection in the United States. Recent trends and future strategies for control. Am J Med (1989) 1.43
Immunization of adolescents. Am Fam Physician (1997) 1.42
Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis (2000) 1.41
Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis (2000) 1.41
Septic arthritis due to Micrococcus luteus. J Rheumatol (1986) 1.39
Measles surveillance--United States, 1991. MMWR CDC Surveill Summ (1992) 1.38
Development of a direct PCR assay for detection of the diphtheria toxin gene. J Clin Microbiol (1997) 1.35
Pertussis--a disease and a vaccine that are not going away. West J Med (1989) 1.35
Are we ready for diphtheria? A report from the Diphtheria Diagnostic Workshop, Atlanta, 11 and 12 July 1994. J Infect Dis (1995) 1.32
Serologic investigation of an outbreak of hepatitis A in a rural day-care center. Am J Public Health (1983) 1.30
Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J Infect Dis (2001) 1.29
The emerging diversity of the electrophoretic types of Vibrio cholerae in the Western Hemisphere. J Infect Dis (1995) 1.28
Lethal outbreak of hepatitis B in a dental practice. JAMA (1986) 1.24
Small animals are not susceptible to human immunodeficiency virus infection. J Gen Virol (1987) 1.24
Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987. JAMA (1990) 1.24
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23
An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine (1999) 1.23
Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis (1995) 1.21